Artificial Ribozymes

Ribozymes exist in nature as catalytic RNA molecules that either aid the hydrolysis of their own phosphodiester bonds or cause the hydrolysis of bonds in other RNAs. They also catalyze the aminotransferase activity of the ribosome. Research into the function and structure of these naturally occurring molecules has led to the development of synthetic ribozymes that are made in the laboratory.

For example, Tang and Breaker used in vitro selection of RNAs from random sequence RNAs to isolate self-cleaving RNAs. These synthetic, self-cleaving RNAs possess a good enzymatic activity that makes them useful in several areas of genetics, genomics and molecular biology. Some of the synthetic ribozymes that have been prepared have unique structures, while others resemble the naturally occurring hammerhead ribozyme. Further examples of ribozymes include the hairpin ribozyme, the Leadzyme and the VS ribozyme.

The methods used to discover artificial ribozymes are based on Darwinian evolution. The approach uses the fact that RNA has the ability to act as both a catalytic molecule as well as source of genetic information (like DNA). This dual nature of RNA provides a huge advantage to the investigator, who finds it easy to produce large populations of RNA catalysts using polymerase enzymes.

Reverse transcriptase is used to mutate these ribozymes by reverse transcribing them into various cDNA which can then be amplified with mutagenic PCR. The selection parameters may vary in these experiments. Biotin tags covalently linked to the substrate are used to select a ligase ribozyme. If a molecule demonstrates the required ligase activity, the active molecule can be recovered using a streptaidin matrix.

Lincoln and Joyce went on to create an RNA enzyme system that could self replicate in around one hour. This system uses molecular competition or in vitro evolution to establish an RNA enzyme pair from a candidate enzyme mixture. Each of the RNA enzymes synthesizes the other from synthetic oligonucleotides, in the absence of any protein.

Further Reading

Last Updated: Jul 20, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 20). Artificial Ribozymes. News-Medical. Retrieved on January 02, 2024 from https://www.news-medical.net/life-sciences/Artificial-Ribozymes.aspx.

  • MLA

    Mandal, Ananya. "Artificial Ribozymes". News-Medical. 02 January 2024. <https://www.news-medical.net/life-sciences/Artificial-Ribozymes.aspx>.

  • Chicago

    Mandal, Ananya. "Artificial Ribozymes". News-Medical. https://www.news-medical.net/life-sciences/Artificial-Ribozymes.aspx. (accessed January 02, 2024).

  • Harvard

    Mandal, Ananya. 2023. Artificial Ribozymes. News-Medical, viewed 02 January 2024, https://www.news-medical.net/life-sciences/Artificial-Ribozymes.aspx.

Comments

  1. sanjeev nirala sanjeev nirala India says:

    Absolutely brilliant

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post